18

October 18, 2018

The tiny probiotic Bb12 may function as a Pain medication:  Probiotic Bifidobacterium animalis ssp. lactis Bb12 (Bb12) increases the expression of PD-L1, attenuates acute and chronic pain, and suppresses mechanical and thermal hypersensitivity and inhibits nociceptive neuron excitability, via up-regulation of its target gene, 18/October/2018, 11.35 pm

Introduction: What they say: A recent study from Institute of Neurobiology, Institutes of Brain Science and State Key Laboratory of Medical Neurobiology, Collaborative Innovation Center for […]
October 18, 2018

A cup of probiotic a day keeps cardiac diseases at bay: Probiotic Lactobacillus pentosus var. plantarum C29 inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up-regulation of PNUTS, 18/October/2018, 11.19 pm

What they say:  A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac aging and function.” This study was published, in the 7 March  2013 issue of the […]
October 18, 2018

The tiny probiotic may safeguard your heart against cardiac dysfunction: Probiotic Lactobacillus pentosus var.plantarum C29-based therapy for cardiomyocyte proliferation and heart regeneration: Probiotic Lactobacillus pentosus var.plantarum C29 decreases tumor suppressor Mir-128 and cyclin-dependent kinase inhibitor p27 expression, increases SUZ12 expression, increases Cyclin E and CDK2 expression, promotes proliferation/re-entry of postnatal/adult cardiomyocytes, attenuates fibrosis, ameliorates cardiac dysfunction, and promotes heart repair in response to myocardial infarction, via up-regulation of its target gene, 18/Ocotober/2018, 11.01 pm

Introduction: What they say: A recent study from Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA; Key Laboratory […]
October 18, 2018

Repurposing the anesthetic agent Sevoflurane as an anxiety-reducing agent: Sevoflurane (Trade name: Sojourn, Ultane, Sevorane) decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression, via down-regulation of its target gene, 18/October/2018, 5.59 am

Introduction: What they say:  A study from Department of Molecular Biology, Cancer Center and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA; Department […]